Personalized screening early in pregnancy may improve preeclampsia detection
Research Highlights:
A personalized screening algorithm for preeclampsia in the first trimester of pregnancy may help clinicians better predict who is at risk for developing the condition and who may benefit from treatment with a daily, low-dose aspirin.
In this study of more than 7,000 women, the new screening method, which combined maternal history, biomarker tests and ultrasound tests, was better at identifying preeclampsia risk in than current risk factor-based guidelines.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, May 6, 2024
DALLAS, May 6, 2024 — A new screening algorithm for preeclampsia combining maternal history, ...















